Abstract 611: Exploratory analyses suggest ovarian tumors with somatic or germline loss of function mutations in <i>BRCA1</i> or <i>BRCA2</i> are biologically similar and sensitive to PARP inhibitionBrian Dougherty, J. Carl Barrett, Jonathan A. Ledermann et al.|Cancer Research|2015Cited by 4